Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia
Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...
The Health Justice Project: Using digital stories to address health disparities as a social justice issue
The purpose of this project is to examine the link between racial and social injustice based on one's minority...
How do chemical exposures trigger autoimmune diseases?
The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...